Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
17.03. | Lipidor AB: Lipidor announces all patients enrolled in ongoing Phase III study | 76 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 17th March 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that all patients in the ongoing Phase III study for the drug candidate AKP02G2 have been... ► Artikel lesen | |
28.02. | Lipidor AB: Lipidor AB (publ) publishes year-end report for 2024 | 121 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 28th February 2025 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the period January - December 2024. The report is available... ► Artikel lesen | |
21.01. | Lipidor AB: Lipidor announces half of patients enrolled in ongoing Phase III study | 387 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 21st January 2025 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today announces that half of the patients in the ongoing Phase III study for the drug candidate AKP02G2... ► Artikel lesen | |
20.11.24 | Lipidor AB: Lipidor publishes CEO statement for the quarter: "Study results expected by the end of Q1 2025" | 101 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 20 November 2024 - Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today provides an update on the business from CEO Ola Holmlund, also announcing a company presentation... ► Artikel lesen | |
28.08.24 | Lipidor AB: Lipidor AB (publ) publishes interim report for Q2 2024 | 109 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 28 August 2024 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the period January - June 2024. The report is available on the... ► Artikel lesen | |
LIPIDOR Aktie jetzt für 0€ handeln | |||||
27.06.24 | Nasdaq Stockholm AB: New equity right for trading, Lipidor AB TO2 | 1.091 | GlobeNewswire | At the request of Lipidor AB, Lipidor AB equity rights will be traded on First
North Growth Market as from June 28, 2024.
Security name: Lipidor AB TO2
------------------------------
Short... ► Artikel lesen | |
26.06.24 | Nasdaq Stockholm AB: The observation status for Lipidor AB is removed | 293 | GlobeNewswire | On December 19, 2022, the shares in Lipidor AB (the "Company") were given
observation status with reference to material adverse uncertainty in respect of
the issuer's financial position.
On April... ► Artikel lesen | |
23.05.24 | XFRA CAPITAL ADJUSTMENT INFORMATION - 23.05.2024 | 850 | Xetra Newsboard | Das Instrument 49S GB00B60BD277 SUPERDRY PLC LS -,01 EQUITY wird ex Kapitalmassnahme gehandelt am 23.05.2024 The instrument 49S GB00B60BD277 SUPERDRY PLC LS -,01 EQUITY is traded ex capital adjustment... ► Artikel lesen | |
22.05.24 | Lipidor AB: Lipidor AB (publ) publishes interim report for Q1 2024 | 180 | GlobeNewswire (Europe) | STOCKHOLM, Sweden, 22 May 2024 - Today, Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its interim report for the period January - March 2024. The report is available on the company's... ► Artikel lesen | |
21.05.24 | Lipidor AB: Bulletin from the Extraordinary General Meeting of Lipidor AB (publ) | 233 | GlobeNewswire (Europe) | The following resolutions were passed at the Extraordinary General Meeting (the "EGM") of Lipidor AB (publ) (the "Company") on 21 May 2024 in Stockholm.
Rights issue of unitsThe EGM resolved to approve... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ORAMED PHARMACEUTICALS | 1,981 | +0,56 % | ORAMED PHARMACEUTICALS INC. - 10-K, Annual Report | ||
MEDMEN ENTERPRISES | - | - | This Week In Cannabis: The MedMen Saga, Multi-Million-Dollar Financings, Controversies In LatAm And More | ||
OPUS GENETICS | 0,844 | -5,91 % | Opus Genetics, Inc.: Opus Genetics Announces Financial Results for Full Year 2024 | Provides update on the Company's transformation and promising portfolio of innovative gene therapy treatments for inherited retinal diseases Strong cash position with $21.5 million financing to supplement... ► Artikel lesen | |
BOIRON | 24,900 | +1,63 % | Boiron USA: Millennials Are the Most Stressed Generation - And It's Costing Them Their Sleep | Newtown Square, Pennsylvania--(Newsfile Corp. - March 13, 2025) - Millennials are more stressed and sleep-deprived than any other generation, and money is largely to blame. According to a new survey... ► Artikel lesen | |
VERTICAL AEROSPACE | 3,240 | +3,18 % | Vertical Aerospace Adopts Universal Fast-Charging Standard to Accelerate eVTOL Deployment | Vertical joins BETA Technologies, Archer Aviation, and much of the industry in adopting the Combined Charging Standard (CCS), as endorsed by the General Aviation Manufacturers Association (GAMA).
... ► Artikel lesen | |
PACIRA BIOSCIENCES | 22,800 | -0,87 % | Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | PARSIPPANY, N.J., March 06, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today announced the granting... ► Artikel lesen | |
RED LIGHT HOLLAND | 0,020 | 0,00 % | Red Light Holland Corp.: Red Light Holland Appoints Michael Galloro to Board of Directors | Toronto, Ontario--(Newsfile Corp. - March 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the... ► Artikel lesen | |
INNOCARE PHARMA | 1,130 | 0,00 % | INNOCARE (09969): TERMS OF REFERENCE FOR THE NOMINATION COMMITTEE | ||
PHIBRO ANIMAL HEALTH | 19,700 | -0,51 % | Should You Bet on PAHC Stock at a Discounted P/E of 10.41X? | ||
BAYER | 22,315 | +1,11 % | Bayer-Aktie mit Glyphosat-Hammer: Milliarden-Crash und Pleiteliste oder Kaufchance? | © Foto: Symbolbild von KATRIN BOLOVTSOVA auf PexelsEinmal hoch und wieder runter, bzw. vom DAX-Riesen zum Juristen-Magneten-Zwerg. Nachfolgend erfahren Sie, warum viele Anleger jetzt die Nerven verlieren... ► Artikel lesen | |
MERCK KGAA | 126,60 | 0,00 % | EQS-DD: Merck KGaA: Belén Garijo Lopez, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
27.03.2025 / 15:59... ► Artikel lesen | |
GSK | 17,790 | +0,91 % | DEUTSCHE BANK RESEARCH stuft GSK auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat die Einstufung für GSK auf "Hold" mit einem Kursziel von 1450 Pence belassen. Laut eigener Umfragen unter HIV-Ärzten und -Patienten zu den HIV-Präparaten... ► Artikel lesen | |
NOVO NORDISK | 63,44 | -1,44 % | Dividendenbekanntmachungen (28.03.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABERDEEN GROUP PLC ADR US00108N1000 0,3716 USD 0,3442 EUR ACOM CO LTD JP3108600002 7 JPY 0,0429 EUR ADVANEX INC JP3213400009 20... ► Artikel lesen | |
PFIZER | 22,795 | -2,71 % | Pfizer Aktie: Branchendaten im Überblick | Pfizer bleibt ein zentraler Akteur für Anleger im Pharmasektor. Die aktuellen Entwicklungen unterstreichen die strategische Positionierung des Unternehmens inmitten globaler wirtschaftlicher Veränderungen... ► Artikel lesen | |
ASTRAZENECA | 136,10 | +1,00 % | JPMORGAN stuft ASTRAZENECA auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Astrazeneca auf "Overweight" mit einem Kursziel von 14000 Pence belassen. Die im laufenden Jahr zu erwartenden Phase-III-Studienergebnisse... ► Artikel lesen |